Evaxion A/S, a clinical-stage TechBio company specializing in developing AI-Immunology powered vaccines, has out-licensed its vaccine candidate EVX-B3 to MSD (tradename of Merck & Co., Inc., Rahway, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback